Literature DB >> 12862034

Use of high-dose cortisone in a patient with Marchiafava-Bignami disease.

Annegrit Gerlach, Eckard Oehm, Jens Wattchow, Sargon Ziyeh, Franz-Xaver Glocker, Thomas Els.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12862034     DOI: 10.1007/s00415-003-1072-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

Review 1.  Clinicoradiologic subtypes of Marchiafava-Bignami disease.

Authors:  Alexander Heinrich; Uwe Runge; Alexander V Khaw
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Acute Marchiafava-Bignami disease presenting as reversible dementia in a chronic alcoholic.

Authors:  Vineet Sehgal; Praveen Kesav; M Modi; Chirag K Ahuja
Journal:  BMJ Case Rep       Date:  2013-02-15

3.  Corticosteroid treatment in a patient with Marchiafava-Bignami disease.

Authors:  A Consoli; D Pirritano; D Bosco; P Postorino; D Consoli
Journal:  Neurol Sci       Date:  2014-03-09       Impact factor: 3.307

Review 4.  Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases.

Authors:  Matti Hillbom; Pertti Saloheimo; Shinsuke Fujioka; Zbigniew K Wszolek; Seppo Juvela; Maurizio A Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-26       Impact factor: 10.154

5.  A Case of Cortical Involvement in Marchiafava-Bignami Disease Accompanying Wernicke's Encephalopathy.

Authors:  Michelle Youn; Jung Ju Lee; Jong Moo Park; Kyusik Kang; Ohyun Kwon; Woong Woo Lee; Byung Kun Kim
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

6.  Marchiafava-bignami disease in a nonalcoholic diabetic patient.

Authors:  Sisira Yadala; Jin Jun Luo
Journal:  Case Rep Neurol Med       Date:  2013-04-24

7.  Marchiafava-Bignami disease with asymmetric extracallosal lesions.

Authors:  Lei Yang; Wei Qin; Ji-Hua Xu; Wen-Li Hu
Journal:  Arch Med Sci       Date:  2015-08-11       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.